We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
LETTER FROM THE EDITORS.
- Authors
Malouf, Devyn; Khatibi, Kimia
- Abstract
The Health Law & Policy Brief, Volume 18, Issue 2, focuses on topics related to substance use, treatment, and regulation in the United States. The issue features two articles: one discussing the federal government's response to emerging treatments involving psychedelic substances, and another highlighting the value of using generic biologics to increase access to medicine. The first article analyzes state and federal policies regarding innovative mental health treatments involving psychedelic substances, while the second article addresses the failures of current regulations to adequately protect participants in foreign clinical trials. The authors provide recommendations for a federal response and argue for more comprehensive regulation of foreign clinical trials by the Food and Drug Administration.
- Subjects
MENTAL health services; NON-commissioned officers
- Publication
Health Law & Policy, 2024, Vol 18, Issue 2, pv
- ISSN
2572-6072
- Publication type
Article